Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Iron Bridge Resources Inc. stock logo
IBR
Iron Bridge Resources
C$0.84
C$0.46
C$0.85
C$130.05MN/A311,087 shs86,099 shs
The Progressive Co. stock logo
PGR
Progressive
$212.20
-0.9%
$201.66
$111.41
$216.21
$124.29B0.352.62 million shs2.63 million shs
Pharming Group stock logo
PHAR
Pharming Group
$9.89
+3.0%
$10.89
$9.27
$16.71
$663.72M0.162,598 shs2,744 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Iron Bridge Resources Inc. stock logo
IBR
Iron Bridge Resources
0.00%0.00%0.00%0.00%0.00%
The Progressive Co. stock logo
PGR
Progressive
-0.85%+1.47%+2.98%+19.21%+57.34%
Pharming Group stock logo
PHAR
Pharming Group
+2.22%-2.75%-12.24%-21.51%-8.93%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Iron Bridge Resources Inc. stock logo
IBR
Iron Bridge Resources
N/AN/AN/AN/AN/AN/AN/AN/A
The Progressive Co. stock logo
PGR
Progressive
4.6035 of 5 stars
2.24.01.72.33.22.53.1
Pharming Group stock logo
PHAR
Pharming Group
2.529 of 5 stars
3.55.00.00.02.60.00.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Iron Bridge Resources Inc. stock logo
IBR
Iron Bridge Resources
N/AN/AN/AN/A
The Progressive Co. stock logo
PGR
Progressive
2.41
Hold$211.88-0.15% Downside
Pharming Group stock logo
PHAR
Pharming Group
3.00
Buy$37.00274.12% Upside

Current Analyst Ratings

Latest PTAL, PGR, PHAR, and IBR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/17/2024
The Progressive Co. stock logo
PGR
Progressive
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$279.00 ➝ $273.00
4/17/2024
The Progressive Co. stock logo
PGR
Progressive
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$216.00 ➝ $218.00
4/15/2024
The Progressive Co. stock logo
PGR
Progressive
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$202.00 ➝ $225.00
4/15/2024
The Progressive Co. stock logo
PGR
Progressive
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$241.00 ➝ $245.00
4/11/2024
The Progressive Co. stock logo
PGR
Progressive
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$232.00 ➝ $238.00
4/11/2024
The Progressive Co. stock logo
PGR
Progressive
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$228.00 ➝ $247.00
4/10/2024
The Progressive Co. stock logo
PGR
Progressive
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$190.00 ➝ $200.00
4/8/2024
The Progressive Co. stock logo
PGR
Progressive
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$171.00 ➝ $202.00
4/2/2024
The Progressive Co. stock logo
PGR
Progressive
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$265.00 ➝ $264.00
4/1/2024
The Progressive Co. stock logo
PGR
Progressive
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$240.00
3/14/2024
Pharming Group stock logo
PHAR
Pharming Group
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$37.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Iron Bridge Resources Inc. stock logo
IBR
Iron Bridge Resources
C$21.83M0.00N/AN/AC$0.56 per share0.00
The Progressive Co. stock logo
PGR
Progressive
$65.02B1.91$6.75 per share31.43$37.24 per share5.70
Pharming Group stock logo
PHAR
Pharming Group
$245.32M2.71$0.10 per share101.77$3.26 per share3.03

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Iron Bridge Resources Inc. stock logo
IBR
Iron Bridge Resources
N/A-C$1.03N/AN/AN/AN/AN/AN/AN/A
The Progressive Co. stock logo
PGR
Progressive
$3.90B$9.7721.7217.890.848.89%29.43%6.26%7/11/2024 (Estimated)
Pharming Group stock logo
PHAR
Pharming Group
-$10.55M-$0.14N/AN/AN/A-4.13%-4.53%-2.14%5/8/2024 (Confirmed)

Latest PTAL, PGR, PHAR, and IBR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2024N/A
Pharming Group stock logo
PHAR
Pharming Group
$0.0050N/A-$0.0050N/AN/AN/A
4/12/2024Q1 2024
The Progressive Co. stock logo
PGR
Progressive
$3.20$3.94+$0.74$3.52$16.88 billion$18.96 billion    
3/14/2024Q4 2023
Pharming Group stock logo
PHAR
Pharming Group
$0.05-$0.03-$0.08-$0.02$71.83 million$81.20 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Iron Bridge Resources Inc. stock logo
IBR
Iron Bridge Resources
N/AN/AN/AN/AN/A
The Progressive Co. stock logo
PGR
Progressive
$0.400.19%-46.76%4.09%N/A
Pharming Group stock logo
PHAR
Pharming Group
N/AN/AN/AN/AN/A

Latest PTAL, PGR, PHAR, and IBR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/1/2024
The Progressive Co. stock logo
PGR
Progressive
quarterly$0.100.21%4/3/20244/4/20244/12/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Iron Bridge Resources Inc. stock logo
IBR
Iron Bridge Resources
4.61
0.46
0.43
The Progressive Co. stock logo
PGR
Progressive
0.32
0.36
0.31
Pharming Group stock logo
PHAR
Pharming Group
0.62
4.06
3.33

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Iron Bridge Resources Inc. stock logo
IBR
Iron Bridge Resources
N/A
The Progressive Co. stock logo
PGR
Progressive
85.34%
Pharming Group stock logo
PHAR
Pharming Group
0.03%

Insider Ownership

CompanyInsider Ownership
Iron Bridge Resources Inc. stock logo
IBR
Iron Bridge Resources
N/A
The Progressive Co. stock logo
PGR
Progressive
0.34%
Pharming Group stock logo
PHAR
Pharming Group
2.07%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Iron Bridge Resources Inc. stock logo
IBR
Iron Bridge Resources
N/A154.82 millionN/ANot Optionable
The Progressive Co. stock logo
PGR
Progressive
61,400585.70 million583.71 millionOptionable
Pharming Group stock logo
PHAR
Pharming Group
33267.11 million65.72 millionNot Optionable

PTAL, PGR, PHAR, and IBR Headlines

SourceHeadline
Pharming to be honored as Industry Innovator at National  Organization for Rare Disorders (NORD®) 2024 Rare Impact AwardsPharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards
finance.yahoo.com - April 24 at 2:17 AM
Pharming Group to report first quarter 2024 financial results on May 8Pharming Group to report first quarter 2024 financial results on May 8
finance.yahoo.com - April 24 at 2:17 AM
Pharming Group (NASDAQ:PHAR) Shares Gap Down to $10.00Pharming Group (NASDAQ:PHAR) Shares Gap Down to $10.00
marketbeat.com - April 22 at 1:31 PM
Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?
zacks.com - April 22 at 6:31 AM
Pharming Group (NASDAQ:PHAR) Sees Large Volume IncreasePharming Group (NASDAQ:PHAR) Sees Large Volume Increase
americanbankingnews.com - April 21 at 4:44 AM
Pharming Group (NASDAQ:PHAR) Hits New 1-Year Low at $9.35Pharming Group (NASDAQ:PHAR) Hits New 1-Year Low at $9.35
americanbankingnews.com - April 20 at 4:40 AM
Pharming Group N.V.: Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025Pharming Group N.V.: Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025
finanznachrichten.de - April 19 at 4:05 PM
Pharming Group (NASDAQ:PHAR) Sees Strong Trading VolumePharming Group (NASDAQ:PHAR) Sees Strong Trading Volume
marketbeat.com - April 19 at 1:37 PM
Pharming Group N.V.: Pharming Group announces the placement of €100 million convertible bonds due 2029Pharming Group N.V.: Pharming Group announces the placement of €100 million convertible bonds due 2029
finanznachrichten.de - April 18 at 6:18 PM
Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025
finance.yahoo.com - April 18 at 8:17 AM
Pharming Group (NASDAQ:PHAR) Stock Price Down 6.8%Pharming Group (NASDAQ:PHAR) Stock Price Down 6.8%
marketbeat.com - April 15 at 1:55 PM
Pharming Group (NASDAQ:PHAR)  Shares Down 5% Pharming Group (NASDAQ:PHAR) Shares Down 5%
marketbeat.com - April 9 at 3:19 PM
Enrollment completed for trial of drug to treat children with rare primary immunodeficiencyEnrollment completed for trial of drug to treat children with rare primary immunodeficiency
outsourcing-pharma.com - April 8 at 8:50 AM
Pharming announces completion of enrollment in pediatric clinical trial of leniolisibPharming announces completion of enrollment in pediatric clinical trial of leniolisib
finance.yahoo.com - April 8 at 1:34 AM
Pharming Group (NASDAQ:PHAR) Shares Gap Down to $10.96Pharming Group (NASDAQ:PHAR) Shares Gap Down to $10.96
marketbeat.com - April 4 at 6:21 PM
Pharming Group announces the filing of its 2023 Annual Report and Form 20-FPharming Group announces the filing of its 2023 Annual Report and Form 20-F
finance.yahoo.com - April 4 at 1:14 AM
Uber to pay $178 million in Australia taxi class action settlementUber to pay $178 million in Australia taxi class action settlement
msn.com - March 18 at 3:45 AM
Pharming reports Q4 resultsPharming reports Q4 results
msn.com - March 15 at 7:46 PM
Pharming Group N.V. 2023 Q4 - Results - Earnings Call PresentationPharming Group N.V. 2023 Q4 - Results - Earnings Call Presentation
seekingalpha.com - March 14 at 9:06 AM
Pharming Group N.V.: Pharming Group to report fourth quarter and full year 2023 financial results on March 14Pharming Group N.V.: Pharming Group to report fourth quarter and full year 2023 financial results on March 14
finanznachrichten.de - February 29 at 6:26 AM
Pharming Group N.V. (PHGN.F)Pharming Group N.V. (PHGN.F)
finance.yahoo.com - February 20 at 3:10 PM
Pharming Group N.V.: Pharming Group to participate in February investor conferencesPharming Group N.V.: Pharming Group to participate in February investor conferences
finanznachrichten.de - February 8 at 3:55 AM
Pharming Group to participate in February investor conferencesPharming Group to participate in February investor conferences
finance.yahoo.com - February 8 at 3:55 AM
Astria Therapeutics: Too Much Risk, Too Little Reward Despite Near-Term Data ReadoutAstria Therapeutics: Too Much Risk, Too Little Reward Despite Near-Term Data Readout
seekingalpha.com - February 5 at 12:52 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Iron Bridge Resources logo

Iron Bridge Resources

TSE:IBR
Iron Bridge Resources Inc. engages in the exploration, development, and production of natural gas, crude oil, and natural gas liquids in Western Canada. It primarily operates in the Montney light oil fairway at Elmworth in West Central Alberta. As of December 31, 2017, its total proved plus probable reserves included 26.11 million barrels of oil equivalent. The company was formerly known as RMP Energy Inc. and changed its name to Iron Bridge Resources Inc. in November 2017. Iron Bridge Resources Inc. is headquartered in Calgary, Canada. As of October 5, 2018, Iron Bridge Resources Inc. operates as a subsidiary of Velvet Energy Ltd.
Progressive logo

Progressive

NYSE:PGR
The Progressive Corporation, an insurance holding company, provides personal and commercial auto, personal residential and commercial property, business related general liability, and other specialty property-casualty insurance products and related services in the United States. It operates in three segments: Personal Lines, Commercial Lines, and Property. The Personal Lines segment writes insurance for personal autos and recreational vehicles (RV). This segment's products include personal auto insurance; and special lines products, including insurance for motorcycles, ATVs, RVs, watercrafts, snowmobiles, and related products. The Commercial Lines segment provides auto-related liability and physical damage insurance, and business-related general liability and property insurance for autos, vans, and pick-up trucks used by small businesses, as well as non-fleet taxis, black-car services, and airport taxis; tractors, trailers, and straight trucks primarily used by regional general freight and expeditor-type businesses, and long-haul operators; dump trucks used by light contractors and heavy constructions; log trucks and garbage trucks used by dirt, sand and gravel, logging, garbage/debris removal, and coal-type businesses; and tow trucks and wreckers used in towing services and gas/service station businesses. The Property segment writes residential property insurance for homeowners, other property owners, and renters, as well as offers manufactured homes, personal umbrella insurance, and primary and excess flood insurance. The company offers policy issuance and claims adjusting services; acts as an agent to homeowners, general liability, workers' compensation insurance, and other products; and reinsurance services. It sells its products through independent insurance agencies, as well as through mobile applications and over the phone. The Progressive Corporation was founded in 1937 and is headquartered in Mayfield Village, Ohio.
Pharming Group logo

Pharming Group

NASDAQ:PHAR
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.